Condition: Metabolic Syndrome · Sponsor: Center of New Medical Technologies
This retrospective cohort study evaluates the association between H. pylori persistence and insulin resistance severity (HOMA-IR) in 100 patients with metabolic syndrome at Novosibirsk's Center for New Medical Technologies (CNMT). Patients are divided into infected (n=50) and non-infected (n=50) groups, assessing metabolic parameters, gastro panel, and CRP. Primary endpoint: HOMA-IR differences; secondary: correlations with gastric inflammation and metabolic markers.
This description comes directly from the study's public registry record.
Evgeniya V Shrainer, PhD · 983 300 22 05 · shrayner_ev@cnmt.ru
Elizaveta K Nemkova, MD · 9512732447 · nemkova_ek@cnmt.ru
Always discuss trial participation with your own doctor first.
| Center of New Medical Technologies | Novosibirsk, Novosibirsk Oblast, Russia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07501858